Infectious Mononucleosis clinical trials

The registry lists 21 studies for Infectious Mononucleosis across 9 countries. 5 are recruiting or about to start. 10 of them are mainly about Infectious Mononucleosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Infectious Mononucleosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 10
Recruiting: 4
Status unknown: 2
Terminated: 2
Not yet recruiting: 1
Active, not recruiting: 1

Phase

Phase 1: 7
Phase 2: 7
Phase 3: 1

Where

United States: 10
Canada: 2
Germany: 2
Denmark: 2
Belgium: 1
Netherlands: 1

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (5) · Technical University of Munich (2) · ModernaTX, Inc. (2) · University of Minnesota (2) · Henogen (1) · Willows Health (1) · Yale University (1) · University of Alberta (1)

What is being tested here

Drugs under test in Infectious Mononucleosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Matrix-M	0	0	1
Valacyclovir	0	0	1
Acyclovir	0	0	1
Bendamustine	0	0	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Dec 2026Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection · University Hospital, Basel, Switzerland
Oct 2027Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection · National Institute of Allergy and Infectious Diseases (NIAID)

Who these studies take

Of the 4 Infectious Mononucleosis studies recruiting now, 1 (25%) set no upper age limit and 2 (50%) stop at 75 or younger. 2 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	2 (50%)	2 (50%)
18	4 (100%)	4 (100%)
30	2 (50%)	2 (50%)
40	2 (50%)	2 (50%)
50	2 (50%)	2 (50%)
65	2 (50%)	2 (50%)
75	2 (50%)	2 (50%)
85	2 (50%)	2 (50%)

Across all 21 studies, recruiting or not: 57% stop at 75 or younger and 52% at 65; 57% take children; 0% are for women only and 0% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. search them.